The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects

Sorafenib is a multikinase inhibitor capable of facilitating apoptosis, mitigating angiogenesis and suppressing tumor cell proliferation. In late-stage hepatocellular carcinoma (HCC), sorafenib is currently an effective first-line therapy. Unfortunately, the development of drug resistance to sorafen...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Weiwei, Chen, Ziyi, Zhang, Wenling, Cheng, Ye, Zhang, Betty, Wu, Fan, Wang, Qian, Wang, Shouju, Rong, Dawei, Reiter, F. P., De Toni, E. N., Wang, Xuehao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292831/
https://www.ncbi.nlm.nih.gov/pubmed/32532960
http://dx.doi.org/10.1038/s41392-020-0187-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292831/
https://www.ncbi.nlm.nih.gov/pubmed/32532960
http://dx.doi.org/10.1038/s41392-020-0187-x

Ejemplares similares